Increasing Cancer Prevalence Drives Growth Of Chemotherapy Market: Key Factor Driving The Growth In The Chemotherapy Market

The Chemotherapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Chemotherapy Market Size During the Forecast Period?
The market size for chemotherapy has seen a swift expansion over the past few years. The value is predicted to escalate from $34 billion in 2024 to approximately $37.78 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. Factors contributing to the growth during this historic period include an increase in cancer cases, advancements in cancer detection methods, innovative drug development, clinical research activities, healthcare accessibility, and public awareness campaigns.

The market size of chemotherapy is anticipated to experience significant expansion in the upcoming years. It is projected to reach a value of $62.22 billion in 2029, with a compound annual growth rate of 13.3%. The expected growth during the forecast period can be associated with the incorporation of immunotherapy, the adoption of biosimilars, the surge in emerging markets, genomic profiling, advancements in supportive care, and regulatory ease. Key trends during this forecast period could be digital health solutions, customized medicine, ongoing cancer research, the amalgamation of artificial intelligence, progress in nanotechnology, and home-based administration of chemotherapy.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9219

What Are the High-Growth Segments in the Chemotherapy Market?
The chemotherapy market covered in this report is segmented -

1) By Product Type: Pump, Cannula, Catheter, Other Product Types
2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer
3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs
4) By Route Of Administration: Oral, Intravenous
5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:
1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps
2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports
3) By Catheter: Chemotherapy Catheters, PICC Lines
4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

What Key Drivers Are Expected to Influence Future Chemotherapy Market Growth?
The chemotherapy market is anticipated to expand due to the escalating prevalence of cancer. Cancer is characterised as a condition where certain body cells proliferate uncontrollably and infiltrate other areas. Chemotherapy employs potent chemicals, either in combination or individually, to exterminate rapidly multiplying cancer cells. The surge in cancer cases will subsequently augment the necessity for chemotherapy. For example, the American Cancer Society Inc., a non-profit health organization in the U.S., predicts that by 2023, new cancer diagnoses will elevate to 1.9 million from 1.8 million in 2020. Furthermore, an estimation of 609,820 cancer-related fatalities is expected in the U.S. in 2023, a slight increase from the projection of 606,520 cancer deaths in 2020. Hence, the rise in the prevalence of cancer is steering the growth in the chemotherapy market.

Which Companies Hold the Largest Share Across Different Chemotherapy Market Segments?
Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

What Trends Are Driving Growth in The Chemotherapy Market?
Leading firms in the chemotherapy industry are aiming to gain a competitive advantage through the development of innovative products, such as chemotherapy infusion pumps. These devices transport chemotherapy medications directly into the bloodstream via an IV line and allow for precise control over the delivery of the drugs. For example, Shanghai MicroPort Lifesciences Co. Ltd, a Chinese medical technology developer and manufacturer, was granted marketing approval for their AutoEx Chemotherapy Infusion Pump by the National Medical Products Administration (NMPA) in China in March 2022. The AutoEx pump is crafted for the continuous or intermittent administration of chemotherapy drugs to patients with cancer. It is engineered to ensure the ideal drug concentration in the bloodstream, boosting the effectiveness of cancer treatments and minimizing side effects. The system contains a dual CPU control system and dual power source, facilitating utmost precision in drug delivery. This setup enhances the level of comfort and safety for patients undergoing chemotherapy.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

What Are the Emerging Geographies for The Chemotherapy Market Growth?
North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chemotherapy Market?
2. What is the CAGR expected in the Chemotherapy Market?
3. What Are the Key Innovations Transforming the Chemotherapy Industry?
4. Which Region Is Leading the Chemotherapy Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.